Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Utilization of cytology smears improves success rates of RNA‐based next‐generation sequencing gene fusion assays for clinically relevant predictive biomarkers
Nisha S. Ramani, Hui Chen, Russell R. Broaddus, et al.
Cancer Cytopathology (2020) Vol. 129, Iss. 5, pp. 374-382
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling
David Kim, Chad Vanderbilt, Soo‐Ryum Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Clinical application of the Lung Cancer Compact PanelTM using various types of cytological specimens in patients with lung cancer
Kei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Lung Cancer (2024) Vol. 189, pp. 107498-107498
Open Access | Times Cited: 7
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 37
Pan-Cancer Molecular Biomarkers: Practical Considerations for the Surgical Pathologist
Pari Jafari, Megan Forrest, Jeremy P. Segal, et al.
Modern Pathology (2025), pp. 100752-100752
Closed Access
Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy
Erin Faber, Horiana B. Grosu, Sharjeel Sabir, et al.
Journal of Clinical Pathology (2021) Vol. 75, Iss. 9, pp. 612-619
Closed Access | Times Cited: 23
Minimally invasive biopsy‐based diagnostics in support of precision cancer medicine
Bo Franzén, Gert Auer, Rolf Lewensohn
Molecular Oncology (2024) Vol. 18, Iss. 11, pp. 2612-2628
Open Access | Times Cited: 3
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma – morphology, molecular characteristics and differential diagnosis
Sabina Berezowska, Marie Maillard, Mark Keyter, et al.
Histopathology (2023) Vol. 84, Iss. 1, pp. 32-49
Open Access | Times Cited: 7
Reference standards for gene fusion molecular assays on cytological samples: an international validation study
Umberto Malapelle, Francesco Pepe, Pasquale Pisapia, et al.
Journal of Clinical Pathology (2021) Vol. 76, Iss. 1, pp. 47-52
Closed Access | Times Cited: 16
Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples
Alexandr A. Romanko, Rimma S. Mulkidjan, Vladislav I. Tiurin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14203-14203
Open Access | Times Cited: 6
Advances in cytology of lung cancer
Deepali Jain, Sinchita Roy‐Chowdhuri
Seminars in Diagnostic Pathology (2021) Vol. 38, Iss. 5, pp. 109-115
Closed Access | Times Cited: 12
Fast and sensitive validation of fusion transcripts in whole-genome sequencing data
Völundur Hafstað, Jari Häkkinen, Helena Persson
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy
Paul Hofman
Journal of Molecular Pathology (2021) Vol. 2, Iss. 2, pp. 147-172
Open Access | Times Cited: 11
Molecular Testing on Cytology for Gene Fusion Detection
Fernando Schmitt, Alessia Di Lorito, Philippe Vielh
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 9
Detection of clinically actionable gene fusions by next‐generation sequencing‐based RNA sequencing of non–small cell lung cancer cytology specimens: A single‐center experience with comparison to fluorescence in situ hybridization
John Diks, Zhenya Tang, Mehmet Altan, et al.
Cancer Cytopathology (2023) Vol. 132, Iss. 1, pp. 41-49
Open Access | Times Cited: 3
Technical aspects of the use of cytopathological specimens for diagnosis and predictive testing in malignant epithelial neoplasms of the lung
Anthony Maddox, Louise Smart
Cytopathology (2021) Vol. 33, Iss. 1, pp. 23-38
Closed Access | Times Cited: 7
Cell block‐based RNA next generation sequencing for detection of gene fusions in lung adenocarcinoma: An institutional experience
Shuanzeng Wei, Jacqueline Talarchek, Min Huang, et al.
Cytopathology (2022) Vol. 34, Iss. 1, pp. 28-34
Closed Access | Times Cited: 5
Assessment of stained direct cytology smears of breast cancer for whole transcriptome and targeted messenger RNA sequencing
Michał Marczyk, Chunxiao Fu, Rosanna Lau, et al.
Cancer Cytopathology (2023) Vol. 131, Iss. 5, pp. 289-299
Closed Access | Times Cited: 2
A decade of change: Trends in the practice of cytopathology at a tertiary care cancer centre
Peyman Dinarvand, Chinhua Liu, Sinchita Roy‐Chowdhuri
Cytopathology (2021) Vol. 32, Iss. 5, pp. 604-610
Closed Access | Times Cited: 4
Specimen Considerations in Molecular Oncology Testing
Qiong Gan, Sinchita Roy‐Chowdhuri
Clinics in Laboratory Medicine (2022) Vol. 42, Iss. 3, pp. 367-383
Closed Access | Times Cited: 3
Cell pellet from fixative medium of transbronchial lung biopsy sample improves lung cancer ancillary test
Juhong Jiang, Chunli Tang, Yuqin Li, et al.
Lung Cancer (2022) Vol. 175, pp. 9-16
Open Access | Times Cited: 3
Expanding the utility of cytology preparations in cancer biomarker testing
Lynette M. Sholl, David H. Hwang
Cancer Cytopathology (2020) Vol. 129, Iss. 5, pp. 337-340
Open Access | Times Cited: 3
Utility of an anchored multiplex polymerase chain reaction‐based fusion assay for diagnosis of soft tissue tumors in cytology
T. Leif Helland, Adam S. Fisch, Ivan Chebib
Cancer Cytopathology (2024) Vol. 132, Iss. 9, pp. 580-587
Closed Access
Maximizing the clinical utility and performance of cytology samples for comprehensive genetic profiling – A report on the impact of process optimization through the analysis of 4,871 cytology samples profiled by MSK-IMPACT
David Kim, Chad Vanderbilt, Soo‐Ryum Yang, et al.
Research Square (Research Square) (2024)
Open Access
Optimization of Tumor Dissection Procedures Leads to Measurable Improvement in the Quality of Molecular Testing
Bryan L. Betz, Corey S. Post, Jennifer Bergendahl, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 10, pp. 876-887
Closed Access
Precision medicine for patients with salivary gland neoplasms: Determining the feasibility of implementing a next-generation sequencing-based RNA assay in a hospital laboratory
Gloria H. Sura, Jim Hsu, Dina R. Mody, et al.
CytoJournal (2024) Vol. 21, pp. 48-48
Open Access
Page 1 - Next Page

Scroll to top